Pharmacokinetic Interactions with FelbamateIn Vitro-In Vivo Correlation

被引：0
|
作者：
Paul Glue
Christopher R. Banfield
James L. Perhach
Gary G. Mather
Jagdish K. Racha
Rene H. Levy
机构：
[1] Schering-Plough Research Institute,Clinical Pharmacology
[2] Wallace Laboratories,Department of Pharmacology
[3] University of Washington,undefined
来源：
Clinical Pharmacokinetics | 1997年 / 33卷
关键词：
Carbamazepine; Valproic Acid; Lamotrigine; Vigabatrin; Oxcarbazepine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This article provides an analysis of the degree of agreement between in vivo interaction studies performed in patients with epilepsy and healthy individuals, and in vitro studies which identified the cytochromes P450 (CYP) inhibited by felbamate and those involved in its metabolism.
引用
收藏
页码：214 / 224
页数：10
相关论文
共 50 条
  • [41] Enantioselective in vitro metabolism and in vitro-in vivo correlation of the herbicide ethofumesate in a human model
    Perovani, Icaro Salgado
    Carro, Daniel Blascke
    Perez de Albuquerque, Nayara Cristina
    Moraes de Oliveira, Anderson Rodrigo
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 187
  • [42] In Vitro-In Vivo Carcinogenicity
    Steinberg, Pablo
    IN VITRO ENVIRONMENTAL TOXICOLOGY - CONCEPTS, APPLICATION AND ASSESSMENT, 2017, 157 : 81 - 96
  • [43] In Vitro-In Vivo Correlation of the Inhibition Potency of Sodium-Glucose Cotransporter Inhibitors in Rat: A Pharmacokinetic and Pharmacodynamic Modeling Approach
    Yamaguchi, Koji
    Kato, Motohiro
    Suzuki, Masayuki
    Hagita, Hitoshi
    Takada, Maiko
    Ayabe, Miho
    Aso, Yoshinori
    Ishigai, Masaki
    Ikeda, Sachiya
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (01): : 52 - 61
  • [44] Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation
    Jeon, Sang-Won
    Park, Jin-Hyun
    Kim, Joo-Eun
    Park, Young-Joon
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (03) : 407 - 416
  • [45] Pharmacokinetic evaluation and In Vitro-In Vivo Correlation (IVIVC) of novel methylene-substituted 3,3′ diindolylmethane (DIM)
    Patel, Apurva R.
    Spencer, Shawn D.
    Chougule, Mahavir B.
    Safe, Stephen
    Singh, Mandip
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 46 (1-2) : 8 - 16
  • [46] Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation
    Sang-Won Jeon
    Jin-Hyun Park
    Joo-Eun Kim
    Young-Joon Park
    Journal of Pharmaceutical Investigation, 2023, 53 : 407 - 416
  • [47] In vitro-in vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using Gastroplus™
    Ali, Hasan
    Verma, Priya Ranjan Prasad
    Dubey, Sunil Kumar
    Venkatesan, Jayachandran
    Seo, Youngwan
    Kim, Se-Kwon
    Singh, Sandeep Kumar
    RSC ADVANCES, 2017, 7 (53): : 33314 - 33326
  • [48] Inhibition of CYP3A by Erythromycin: In Vitro-In Vivo Correlation in Rats
    Zhang, Xin
    Galinsky, Raymond E.
    Kimura, Robert E.
    Quinney, Sara K.
    Jones, David R.
    Hall, Stephen D.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) : 61 - 72
  • [49] In Vitro-In Vivo Correlation Of Amorphous Solid Dispersion Enabled Itraconazole Tablets
    Coutinho, Ana L.
    Adhikari, Asmita
    Krug, Samuel
    Kane, Maureen
    Hollenbeck, R. Gary
    Hoag, Stephen W.
    Polli, James E.
    PHARMACEUTICAL RESEARCH, 2025, 42 (03) : 485 - 502
  • [50] In vitro-in vivo correlation in nanocarriers: From protein corona to therapeutic implications
    Agnihotri, Tejas Girish
    Alexander, Amit
    Agrawal, Mukta
    Dubey, Sunil Kumar
    Jain, Aakanchha
    JOURNAL OF CONTROLLED RELEASE, 2023, 354 : 794 - 809
12345